Skanditek Industrifoervaltnings AB. The Group's principal activity is the investment and development of listed and unlisted Swedish companies. The Group operates through the following divisions: Services and trade: Information technology and Internet based companies; Technology: Production and assembly of advanced industrial components, electronic equipment and products; Biotechnology: Development and manufacture of products and instruments for tissue dialysis and the development of novel small molecule therapeutics for the treatment of neurological and psychiatric disorders. MYDATA automation accounted for 88% of 2002 revenues and CMA Microdialysis, 12 %.